154 related articles for article (PubMed ID: 23162660)
1. Endogenous cGMP-dependent protein kinase reverses EGF-induced MAPK/ERK signal transduction through phosphorylation of VASP at Ser239.
Tao Y; Gu YJ; Cao ZH; Bian XJ; Lan T; Sang JR; Jiang L; Wang Y; Qian H; Chen YC
Oncol Lett; 2012 Nov; 4(5):1104-1108. PubMed ID: 23162660
[TBL] [Abstract][Full Text] [Related]
2. Type II cGMP-dependent protein kinase inhibits EGF-triggered signal transduction of the MAPK/ERK-mediated pathway in gastric cancer cells.
Wu Y; Chen Y; Qu R; Lan T; Sang J
Oncol Rep; 2012 Feb; 27(2):553-8. PubMed ID: 22012247
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide/cyclic guanosine monophosphate inducers sodium nitroprusside and L-arginine inhibit the proliferation of gastric cancer cells via the activation of type II cyclic guanosine monophosphate-dependent protein kinase.
Yao X; Wu Y; Zhu M; Qian H; Chen Y
Oncol Lett; 2015 Jul; 10(1):479-484. PubMed ID: 26171055
[TBL] [Abstract][Full Text] [Related]
4. Type II cGMP-dependent protein kinase inhibits epidermal growth factor-induced phosphatidylinositol-3-kinase/Akt signal transduction in gastric cancer cells.
Wu M; Chen Y; Jiang L; Li Y; Lan T; Wang Y; Qian H
Oncol Lett; 2013 Dec; 6(6):1723-1728. PubMed ID: 24273605
[TBL] [Abstract][Full Text] [Related]
5. PKG II inhibits EGF/EGFR-induced migration of gastric cancer cells.
Jiang L; Lan T; Chen Y; Sang J; Li Y; Wu M; Tao Y; Wang Y; Qian H; Gu L
PLoS One; 2013; 8(4):e61674. PubMed ID: 23613900
[TBL] [Abstract][Full Text] [Related]
6. Type II cyclic guanosine monophosphate-dependent protein kinase inhibits epidermal growth factor receptor activation in different cancer cell lines.
Jiang LU; Wu M; Wu Y; Lan T; Wang Y; Qian H; Chen Y
Oncol Lett; 2015 Jun; 9(6):2781-2786. PubMed ID: 26137146
[TBL] [Abstract][Full Text] [Related]
7. Type II cGMP-dependent protein kinase inhibits ERK/JNK-mediated activation of transcription factors in gastric cancer cells.
Sang J; Chen Y; Jiang L; Tao Y; Wu Y; Wang Y; Li Y; Lan T; Shao G
Mol Med Rep; 2012 Nov; 6(5):1190-4. PubMed ID: 22940826
[TBL] [Abstract][Full Text] [Related]
8. Type II cGMP-dependent protein kinase inhibits ligand‑induced activation of EGFR in gastric cancer cells.
Jiang L; Chen Y; Li Y; Lan T; Wu M; Wang Y; Qian H
Mol Med Rep; 2014 Apr; 9(4):1405-9. PubMed ID: 24534906
[TBL] [Abstract][Full Text] [Related]
9. Type II cGMP-dependent protein kinase inhibits EGF-induced MAPK/JNK signal transduction in breast cancer cells.
Lan T; Chen Y; Sang J; Wu Y; Wang Y; Jiang L; Tao Y
Oncol Rep; 2012 Jun; 27(6):2039-44. PubMed ID: 22427012
[TBL] [Abstract][Full Text] [Related]
10. A predominant role for cAMP-dependent protein kinase in the cGMP-induced phosphorylation of vasodilator-stimulated phosphoprotein and platelet inhibition in humans.
Li Z; Ajdic J; Eigenthaler M; Du X
Blood; 2003 Jun; 101(11):4423-9. PubMed ID: 12576312
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylation of vasodilator-stimulated phosphoprotein Ser239 suppresses filopodia and invadopodia in colon cancer.
Zuzga DS; Pelta-Heller J; Li P; Bombonati A; Waldman SA; Pitari GM
Int J Cancer; 2012 Jun; 130(11):2539-48. PubMed ID: 21702043
[TBL] [Abstract][Full Text] [Related]
12. Association of VASP with TRPC4 in PKG-mediated inhibition of the store-operated calcium response in mesangial cells.
Wang X; Pluznick JL; Settles DC; Sansom SC
Am J Physiol Renal Physiol; 2007 Dec; 293(6):F1768-76. PubMed ID: 17913834
[TBL] [Abstract][Full Text] [Related]
13. Increased endogenous PKG I activity attenuates EGF-induced proliferation and migration of epithelial ovarian cancer via the MAPK/ERK pathway.
Lan T; Li Y; Wang Y; Wang ZC; Mu CY; Tao AB; Gong JL; Zhou Y; Xu H; Li SB; Gu B; Ma P; Luo L
Cell Death Dis; 2023 Jan; 14(1):39. PubMed ID: 36653376
[TBL] [Abstract][Full Text] [Related]
14. Type II, but not type I, cGMP-dependent protein kinase reverses bFGF-induced proliferation and migration of U251 human glioma cells.
Cao ZH; Tao Y; Sang JR; Gu YJ; Bian XJ; Chen YC
Mol Med Rep; 2013 Apr; 7(4):1229-34. PubMed ID: 23404188
[TBL] [Abstract][Full Text] [Related]
15. PKG II effectively reversed EGF-induced protein expression alterations in human gastric cancer cell lines.
Qian H; Tao Y; Jiang L; Wang Y; Lan T; Wu M; Pang J; Appiah-Kubi K; Chen Y; Wu Y
Cell Biol Int; 2018 Apr; 42(4):435-442. PubMed ID: 29150923
[TBL] [Abstract][Full Text] [Related]
16. Type II cyclic guanosine monophosphate-dependent protein kinase inhibits Rac1 activation in gastric cancer cells.
Wang Y; Chen Y; Wu M; Lan T; Wu Y; Li Y; Qian H
Oncol Lett; 2015 Jul; 10(1):502-508. PubMed ID: 26171059
[TBL] [Abstract][Full Text] [Related]
17. Cyclic Guanosine Monophosphate (cGMP)-Dependent Protein Kinase II Blocks Epidermal Growth Factor (EGF)/Epidermal Growth Factor Receptor (EGFR)-Induced Biological Effects on Osteosarcoma Cells.
Li D; Hua Y; Jiang L; Huang Y; Yue J; Wu Y; Chen Y
Med Sci Monit; 2018 Apr; 24():1997-2002. PubMed ID: 29617357
[TBL] [Abstract][Full Text] [Related]
18. Concentration and regulation of cyclic nucleotides, cyclic-nucleotide-dependent protein kinases and one of their major substrates in human platelets. Estimating the rate of cAMP-regulated and cGMP-regulated protein phosphorylation in intact cells.
Eigenthaler M; Nolte C; Halbrügge M; Walter U
Eur J Biochem; 1992 Apr; 205(2):471-81. PubMed ID: 1315268
[TBL] [Abstract][Full Text] [Related]
19. Type II cGMP-dependent protein kinase phosphorylates EGFR at threonine 669 and thereby inhibits its activation.
Lan T; Pang J; Wang Z; Wang Y; Qian H; Chen Y; Wu Y
Biochem Biophys Res Commun; 2019 Oct; 518(1):14-18. PubMed ID: 31395339
[TBL] [Abstract][Full Text] [Related]
20. Type II cGMP-dependent protein kinase inhibits activation of key members of the RTK family in gastric cancer cells.
Jiang L; Chen Y; Sang J; Li Y; Lan T; Wang Y; Tao Y; Qian H
Biomed Rep; 2013 May; 1(3):399-404. PubMed ID: 24648957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
